Phreesia, Inc. (PHR)
NYSE: PHR · Real-Time Price · USD
28.00
-0.65 (-2.27%)
Aug 14, 2025, 2:03 PM - Market open

Phreesia Revenue

Phreesia had revenue of $115.94M in the quarter ending April 30, 2025, with 14.54% growth. This brings the company's revenue in the last twelve months to $434.53M, up 16.29% year-over-year. In the fiscal year ending January 31, 2025, Phreesia had annual revenue of $419.81M with 17.83% growth.

Revenue (ttm)
$434.53M
Revenue Growth
+16.29%
P/S Ratio
3.83
Revenue / Employee
$208,709
Employees
2,082
Market Cap
1.67B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jan 31, 2025419.81M63.51M17.83%
Jan 31, 2024356.30M75.39M26.84%
Jan 31, 2023280.91M67.68M31.74%
Jan 31, 2022213.23M64.56M43.42%
Jan 31, 2021148.68M23.89M19.15%
Jan 31, 2020 Pro Pro Pro
Jan 31, 2019 Pro Pro Pro
Jan 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 422.82B
Johnson & Johnson 90.63B
Merck & Co. 63.62B
AbbVie 58.33B
AstraZeneca 56.50B
Novartis AG 55.19B
Eli Lilly and Company 53.26B
Novo Nordisk 49.11B
Revenue Rankings